Logo image of ASST

STRIVE INC-A (ASST) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ASST - US8629451027 - Common Stock

0.8146 USD
-0.05 (-5.5%)
Last: 12/26/2025, 8:00:00 PM
0.8226 USD
+0.01 (+0.98%)
After Hours: 12/26/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, ASST scores 3 out of 10 in our fundamental rating. ASST was compared to 235 industry peers in the Capital Markets industry. While ASST has a great health rating, there are worries on its profitability. ASST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ASST had negative earnings in the past year.
ASST had a negative operating cash flow in the past year.
In multiple years ASST reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ASST reported negative operating cash flow in multiple years.
ASST Yearly Net Income VS EBIT VS OCF VS FCFASST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.87%, ASST is doing worse than 91.60% of the companies in the same industry.
The Return On Equity of ASST (-27.33%) is worse than 81.51% of its industry peers.
Industry RankSector Rank
ROA -26.87%
ROE -27.33%
ROIC N/A
ROA(3y)-177.91%
ROA(5y)-95.32%
ROE(3y)-273.24%
ROE(5y)-137.03%
ROIC(3y)N/A
ROIC(5y)N/A
ASST Yearly ROA, ROE, ROICASST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

ASST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASST Yearly Profit, Operating, Gross MarginsASST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

8

2. Health

2.1 Basic Checks

The number of shares outstanding for ASST has been increased compared to 1 year ago.
There is no outstanding debt for ASST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ASST Yearly Shares OutstandingASST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
ASST Yearly Total Debt VS Total AssetsASST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 29.84 indicates that ASST is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 29.84, ASST belongs to the top of the industry, outperforming 97.48% of the companies in the same industry.
ASST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.84
ROIC/WACCN/A
WACCN/A
ASST Yearly LT Debt VS Equity VS FCFASST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

ASST has a Current Ratio of 11.97. This indicates that ASST is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 11.97, ASST belongs to the top of the industry, outperforming 92.02% of the companies in the same industry.
A Quick Ratio of 11.97 indicates that ASST has no problem at all paying its short term obligations.
The Quick ratio of ASST (11.97) is better than 92.02% of its industry peers.
Industry RankSector Rank
Current Ratio 11.97
Quick Ratio 11.97
ASST Yearly Current Assets VS Current LiabilitesASST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.89% over the past year.
ASST shows a strong growth in Revenue. In the last year, the Revenue has grown by 318.64%.
Measured over the past years, ASST shows a decrease in Revenue. The Revenue has been decreasing by -8.60% on average per year.
EPS 1Y (TTM)55.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.39%
Revenue 1Y (TTM)318.64%
Revenue growth 3Y-8.6%
Revenue growth 5YN/A
Sales Q2Q%660.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASST Yearly Revenue VS EstimatesASST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K 800K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASST. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASST Price Earnings VS Forward Price EarningsASST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASST Per share dataASST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ASST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

STRIVE INC-A

NASDAQ:ASST (12/26/2025, 8:00:00 PM)

After market: 0.8226 +0.01 (+0.98%)

0.8146

-0.05 (-5.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2025-11-14
Earnings (Next)03-30 2026-03-30
Inst Owners50.33%
Inst Owner Change879.05%
Ins Owners0.14%
Ins Owner Change1.04%
Market Cap664.29M
Revenue(TTM)2.10M
Net Income(TTM)-212.99M
AnalystsN/A
Price TargetN/A
Short Float %15.07%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 316.34
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.96
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.87%
ROE -27.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-177.91%
ROA(5y)-95.32%
ROE(3y)-273.24%
ROE(5y)-137.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 239.35%
Cap/Sales 18.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.97
Quick Ratio 11.97
Altman-Z 29.84
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)318.64%
Revenue growth 3Y-8.6%
Revenue growth 5YN/A
Sales Q2Q%660.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-588.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-972.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-962.6%
OCF growth 3YN/A
OCF growth 5YN/A

STRIVE INC-A / ASST FAQ

What is the ChartMill fundamental rating of STRIVE INC-A (ASST) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ASST.


Can you provide the valuation status for STRIVE INC-A?

ChartMill assigns a valuation rating of 0 / 10 to STRIVE INC-A (ASST). This can be considered as Overvalued.


What is the profitability of ASST stock?

STRIVE INC-A (ASST) has a profitability rating of 1 / 10.


How financially healthy is STRIVE INC-A?

The financial health rating of STRIVE INC-A (ASST) is 8 / 10.